Will next generation sequencing improve treatment outcomes: Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients
Recent advances in the targeted re-sequencing application on next generation sequencing instrumentation have established this method as a powerful tool in assessing the mutational status of oncology patient samples…

